Skip to content

Study of the Location of Motor Cortical Stimulation Electrodes in Chronic Neuropathic Refractory Patients

Study of the Location of Motor Cortical Stimulation Electrodes in Chronic Neuropathic Refractory Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06216717
Enrollment
100
Registered
2024-01-22
Start date
2023-11-13
Completion date
2027-06-25
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic Pain

Brief summary

Cortical stimulation has been used since 1991 to treat neuropathic pain. However, the underlying mechanisms are still incompletely understood and under-studied. In this protocol, the investigators aim to study the myeloarchitectonic and functional characteristics of areas activated by cortical epidural electrodes and to determine their relation to therapy response in chronic neuropathic refractory pain patients.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* adults * patient implanted with a motor cortical stimulation system for chronic neuropathic refractory pain, * patient with available postoperative scanner

Exclusion criteria

None

Design outcomes

Primary

MeasureTime frameDescription
Pourcentage of pain relief1 yearpercentage of pain relief for different stimulated areas

Secondary

MeasureTime frameDescription
location of leads on the postoperative imaging1 monthlocation of leads on the postoperative imaging

Countries

France

Contacts

CONTACTPetru ISAN
isan.p@chu-nice.fr0642619135
CONTACTCynthia CAILLON
caillon.c@chu-nice.fr0492034589
PRINCIPAL_INVESTIGATORPetru ISAN

Centre Hospitalier Universitaire de Nice

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026